REBYOTA™ Prospective Registry
Completed · NCT05835219
Conditions: Recurrence of Clostridium Difficile Infection
At a glance
- Research payments reported, 2025
- $234,684
- U.S. investigators named
- 38
- Sites paid
- 37
- Planned or actual enrollment
- 145
About the trial
- Sponsor
- Ferring Pharmaceuticals
- Tested
- REBYOTA™ (drug)
- Dates
- Started 2023-06-19; completion 2025-08-29
- Results posted
- Not yet
This is a prospective observational cohort study designed to collect data on patients who received REBYOTA™ for the prevention of rCDI in the routine care setting. As all data collected for this study are observational, the decision to prescribe REBYOTA™ is at the treating physician's discretion and independent from the decision to enroll the patient in the study. Data will be collected from patients' medical records after obtaining informed consent. Data about clinical history, CDI events (primary and recurrent: severity, treatment), CDI-related symptoms, treatments, medical procedures, Adverse Events(AEs), and healthcare resource utilization (i.e., hospitalizations and re-admissions) wi…
From ClinicalTrials.gov, last updated 2026-01-28. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Ferring Pharmaceuticals As reported $234,684 in research payments for this study in 2025 (121 payments).
Products named: Rebyota
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Bruce M. Jones, MD Family Medicine · Autaugaville, AL
- Sharon Rimon, FNP-BC Nurse Practitioners · Mesa, AZ
- Erick H. Alayo, M.D. Gastroenterology · Chula Vista, CA
- Ronald Hsu, MD Gastroenterology · Roseville, CA
- Thuan Le, M.D. Infectious Disease · Murrieta, CA
- Behnam Moein Jahromi, M.D. Gastroenterology · Oceanside, CA
- Paul Feuerstadt, M.D. Gastroenterology · Hamden, CT
- Tawfik Chami, MD Gastroenterology · Zephyrhills, FL
- Cynthia A. Mayer, DO Infectious Disease · Tampa, FL
- Udayakumar Navaneethan, MD Gastroenterology · Saint Petersburg, FL
- Gary P. Wang, MD, PHD Infectious Disease · Gainesville, FL
- Ravi K. Kamepalli, M.D. Infectious Disease · Lagrange, GA
- Colleen S. Kraft, M.D. Infectious Disease · Atlanta, GA
- Divya Ashat, M.D. Gastroenterology · Iowa City, IA
- Ayokunle T. Abegunde, M.D. Gastroenterology · Maywood, IL
- Dejan Micic Gastroenterology · Chicago, IL
- Maha A. Assi, MD Infectious Disease · Wichita, KS
- Julie M. Castex Clinical Nurse Specialist · New Orleans, LA
- Jessica R. Allegretti, M.D. Gastroenterology · Boston, MA
- Ali Alsaadi, M.D. Internal Medicine · Farmington Hills, MI
- Lea M. Monday, M.D. Infectious Disease · Royal Oak, MI
- Mayur Ramesh, MD Infectious Disease · Detroit, MI
- George Abraham, MD Family Medicine · Vicksburg, MS
- Avish Nagpal, MD Infectious Disease · Fargo, ND
- Trevor C. Van Schooneveld, M.D. Infectious Disease · Omaha, NE
- Suraj K. Saggar, D.O. Infectious Disease · Englewood, NJ
- Olga C. Aroniadis, M.D. Internal Medicine · Stony Brook, NY
- Jordan E. Axelrad, M.D., M.P.H Gastroenterology · New York, NY
- Carl V. Crawford JR., M.D. Gastroenterology · New York, NY
- Caterina Oneto Araya, M.D. Gastroenterology · New York, NY
- Loren P. Brook, M.D. Gastroenterology · Cincinnati, OH
- Mazen Issa, MD Gastroenterology · Cleveland, OH
- Micah A. Jacobs, MD Infectious Disease · Pittsburgh, PA
- Scott R. Curry, M.D. Infectious Disease · Charleston, SC
- Johnny Altawil, M.D. Internal Medicine · Knoxville, TN
- Mezgebe Berhe, MD Infectious Disease · Dallas, TX
- Christopher Fan, M.D. Gastroenterology · Houston, TX
- Cirle A. Warren, M.D. Infectious Disease · Charlottesville, VA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Scripps Mercy Hospital, CA $33,709
- University of Florida $21,508
- Baycare Health System Inc $16,125
- Loyola University of Chicago $15,354
- University of Cincinnati $14,950
- Wayne State University $12,690
- University of Iowa Hospital & Clinics, IA $11,417
- Henry Ford Health Hospital, MI $10,950
- NYU Grossman School of Medicine $10,155
- Brigham and Women's Hospital, MA $8,450
- Paramount Medical Research and Consulting LLC $8,000
- The Research Foundation for The State University of New York $7,050
- Houston Methodist Hospital, TX $6,780
- Unehealth $6,700
- Emory University Hospital, GA $5,661
- Weill Medical College of Cornell University $5,645
- Ochsner Medical Center Acute, LA $4,400
- Orlando Health, FL $4,250
- Medical Research Center of Connecticut LLC $3,900
- Holy Name Medical Center Inc $3,500
- North Texas Infectious $3,200
- Gia Clinical Trials LLC $3,000
- Arizona Health Research $2,175
- Med Ped Id Incorporated $1,800
- University of Virginia Medical Center, VA $1,725
- Medical University of South Carolina $1,700
- Regional Infectious Disease Infusion Ctr $1,700
- Romano Pontzer and Associates Limited $1,350
- Ohi West Medical Group II LLC $1,300
- Sanford Research $1,125
- Bioscope Clinical Research $1,000
- Idc Clinical Research LLC $975
- Sutter Medical Center, Sacramento, CA $850
- Candler Hospital Inc $650
- Partners in Internal Medicine PC $625
- Manhattan Clinical Research LLC $250
- Erick H Alayo Medical Corporation $65
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.